Literature DB >> 578625

Somatomedin production in normal adults and cirrhotic patients.

R M Schimpff, D Lebrec, M Donnadieu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 578625     DOI： 10.1530/acta.0.0860355

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN： 0001-5598


× No keyword cloud information.
  11 in total

1.  Effect of IGF-I on total serum antioxidant status in cirrhotic rats.

Authors:  M García-Fernández; I Castilla-Cortázar; M Díaz-Sánchez; F Díez Caballero; A Castilla; A Díaz Casares; I Varela-Nieto; S González-Barón
Journal:  J Physiol Biochem       Date:  2003-06       Impact factor: 4.158

2.  Insulin-like growth factor I improves intestinal barrier function in cirrhotic rats.

Authors:  V Lorenzo-Zúñiga; C M Rodríguez-Ortigosa; R Bartolí; M-L Martínez-Chantar; L Martínez-Peralta; A Pardo; I Ojanguren; J Quiroga; R Planas; J Prieto
Journal:  Gut       Date:  2006-01-24       Impact factor: 23.059

3.  Effects of IGF-I treatment on osteopenia in rats with advanced liver cirrhosis.

Authors:  A Cemborain; I Castilla-Cortázar; M García; B Muguerza; G Delgado; M Díaz-Sánchez; A Picardi
Journal:  J Physiol Biochem       Date:  2000-06       Impact factor: 4.158

Review 4.  Involvement of brain catecholamines and acetylcholine in growth hormone hypersecretory states. Pathophysiological, diagnostic and therapeutic implications.

Authors:  E E Müller; M Rolla; E Ghigo; D Belliti; E Arvat; A Andreoni; A Torsello; V Locatelli; F Camanni
Journal:  Drugs       Date:  1995-11       Impact factor: 9.546

5.  Insulin-like growth factor I: a good indicator of functional hepatocellular capacity in alcoholic liver cirrhosis.

Authors:  A Caufriez; P Reding; D Urbain; J Golstein; G Copinschi
Journal:  J Endocrinol Invest       Date:  1991-04       Impact factor: 4.256

6.  Hematotesticular barrier is altered from early stages of liver cirrhosis: effect of insulin-like growth factor 1.

Authors:  Inma Castilla-Cortazar; Nieves Diez; Maria Garcia-Fernandez; Juan-Enrique Puche; Fernando Diez-Caballero; Jorge Quiroga; Matias Diaz-Sanchez; Alberto Castilla; Amelia-Diaz Casares; Isabel Varela-Nieto; Jesus Prieto; Salvador Gonzalez-Baron
Journal:  World J Gastroenterol       Date:  2004-09-01       Impact factor: 5.742

7.  Serum concentrations of insulin-like growth factor-I (igf-I) as a marker of liver fibrosis in patients with chronic hepatitis C.

Authors:  Vicente Lorenzo-Zúñiga; Ramon Bartolí; Helena Masnou; Silvia Montoliu; Rosa Ma Morillas; Ramon Planas
Journal:  Dig Dis Sci       Date:  2007-04-05       Impact factor: 3.199

8.  Jejunal microvilli atrophy and reduced nutrient transport in rats with advanced liver cirrhosis: improvement by Insulin-like Growth Factor I.

Authors:  Inma Castilla-Cortázar; María Pascual; Elena Urdaneta; Javier Pardo; Juan Enrique Puche; Bárbara Vivas; Amelia Díaz-Casares; María García; Matías Díaz-Sánchez; Isabel Varela-Nieto; Alberto Castilla; Salvador González-Barón
Journal:  BMC Gastroenterol       Date:  2004-06-14       Impact factor: 3.067

9.  Antioxidant effects of insulin-like growth factor-I (IGF-I) in rats with advanced liver cirrhosis.

Authors:  María García-Fernández; Inma Castilla-Cortázar; Matías Díaz-Sanchez; Iñigo Navarro; Juan Enrique Puche; Alberto Castilla; Amelia Díaz Casares; Encarna Clavijo; Salvador González-Barón
Journal:  BMC Gastroenterol       Date:  2005-03-03       Impact factor: 3.067

Review 10.  Type I insulin-like growth factor as a liver reserve assessment tool in hepatocellular carcinoma.

Authors:  Reham Abdel-Wahab; Samir Shehata; Manal M Hassan; Mouhammed A Habra; Ghazaleh Eskandari; Peggy T Tinkey; Jennifer Mitchell; Ju-Seog Lee; Hesham M Amin; Ahmed O Kaseb
Journal:  J Hepatocell Carcinoma       Date:  2015-09-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.